Neural Noise

Safety assessment of temporal interference stimulation

3 min read

  • Temporal interference (TI) uses two high-frequency electric fields to create a low-frequency amplitude-modulated envelope at their intersection, enabling non-invasive targeting of deep brain regions.1
  • In vivo safety of TI is under study; systematic evaluation of acute thermal and cellular safety has been reported.1 1

Gardner updates

  • Transcranial temporal interference stimulation (tTIS) feasibility was demonstrated for treating bipolar disorder with depressive episodes in a Nature study. 2

Weekly enrichment (2026-07-20)

  • The safety study (Frontiers in Neuroscience, 2026; DOI 10.3389/fnins.2026.1751719; PubMed 41788550) used a multi-modal design: an in vitro egg-white model to gauge thermal/coagulation effects plus an invasive in vivo mouse model targeting the hippocampus.34
  • In the egg-white model, TI stimulation at 10 mA (carriers of 1,000 Hz and 1,005 Hz, generating a 5 Hz envelope, for 20 min) produced no visible protein coagulation, whereas conventional 5 Hz alternating-current stimulation (tACS) at the same 10 mA caused localized coagulation, isolating the low-frequency envelope as lower-risk than a real low-frequency current.3
  • In mice, intracranial TI stimulation (2 mA, 1,000/1,005 Hz, 20 min) to the hippocampus produced only a mild and stable temperature increase of about 0.7 °C at the stimulation site.3
  • Histology showed a spatially restricted rise in astrocyte activation (GFAP) confined to the stratum lacunosum-moleculare (SLM), with no significant change in the heat-stress marker HSP70 or the inflammatory/vasodilation marker iNOS across the hippocampus.3
  • The mechanistic rationale is that biological tissue behaves capacitively, so its capacitive impedance falls with frequency; the kilohertz carrier frequencies therefore deposit less heat than an equivalent low-frequency current.3
  • Reported group structure: a temperature cohort of n=4 mice, plus a separate histology cohort split into TI, Sham (two identical 1 kHz carriers producing no amplitude modulation), and Control (electrodes placed, no current), with brains perfused ~24 h post-stimulation and marker expression quantified in ImageJ.5
  • The authors conclude TI has a favorable acute short-term safety profile, while cautioning that group sizes were small, that localized GFAP reactivity warrants follow-up, and that long-term effects remain unstudied; they frame the results as supporting potential use in deep-brain targets such as epilepsy.35
  • Context: a 2025 Frontiers review synthesized 63 TI publications (June 2017–December 2024) spanning safety, finite-element-method modeling, and parameter optimization for deep targets (epilepsy, Parkinson’s disease, cognitive impairment), and argued that TI needs its own physiologically grounded safety guidelines rather than ones adapted from tACS/tDCS.6

Footnotes

  1. https://www.frontiersin.org/articles/10.3389/fnins.2026.1751719 ↩ ↩2 ↩3

  2. https://news.google.com/rss/articles/CBMiX0FVX3lxTE4wU1plczJoWHdIelh1SFpOT3JTMmxOeVllYzJVbks4Rl9VNmlOMVlpUzZrUTc5MHFkVEJKeTRGenlZcFFZb1VQaVFHb0lHaVNGMy1qMTVOdlZCUWdqUWFN?oc=5 ↩

  3. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1751719/full ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  4. https://pubmed.ncbi.nlm.nih.gov/41788550/ ↩

  5. https://aesnet.org/abstractslisting/safety-assessment-of-temporal-interference-non-invasive-intracranial-stimulation ↩ ↩2

  6. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1661049/full ↩

Graph View